scholarly journals Homozygous hemoglobin Knossos (alpha 2 beta 227(B9) Ala----Ser): a new variety of beta+-thalassemia intermedia associated with delta degree- thalassemia

Blood ◽  
1986 ◽  
Vol 67 (4) ◽  
pp. 957-961 ◽  
Author(s):  
F Baklouti ◽  
E Dorleac ◽  
L Morle ◽  
P Laselve ◽  
D Peyramond ◽  
...  

Hb Knossos (beta 27 (B9) Ala----Ser) is a recently discovered hemoglobin variant endowed with beta-thalassemic properties (1,2) We present the first homozygous cases. The propositus, a 19-year-old man is originally from northeast Algeria, but is unrelated to other Algerians who have hemoglobin Knossos. He has a beta+-thalassemia intermedia syndrome, including microcytic, hypochromic anemia, enlargement of the spleen, and an increase in the number of reticulocytes. The reduction of beta-chain synthesis is pronounced (alpha/non alpha:2.76). Whole cells containing Hb Knossos have a dramatically low oxygen affinity (P50:38 mm Hg). The propositus also has homozygous delta degrees-thalassemia. The chromosome carrying these mutations is characterized by the DNA haplotype I.

Blood ◽  
1986 ◽  
Vol 67 (4) ◽  
pp. 957-961
Author(s):  
F Baklouti ◽  
E Dorleac ◽  
L Morle ◽  
P Laselve ◽  
D Peyramond ◽  
...  

Abstract Hb Knossos (beta 27 (B9) Ala----Ser) is a recently discovered hemoglobin variant endowed with beta-thalassemic properties (1,2) We present the first homozygous cases. The propositus, a 19-year-old man is originally from northeast Algeria, but is unrelated to other Algerians who have hemoglobin Knossos. He has a beta+-thalassemia intermedia syndrome, including microcytic, hypochromic anemia, enlargement of the spleen, and an increase in the number of reticulocytes. The reduction of beta-chain synthesis is pronounced (alpha/non alpha:2.76). Whole cells containing Hb Knossos have a dramatically low oxygen affinity (P50:38 mm Hg). The propositus also has homozygous delta degrees-thalassemia. The chromosome carrying these mutations is characterized by the DNA haplotype I.


FEBS Letters ◽  
1985 ◽  
Vol 184 (1) ◽  
pp. 10-13 ◽  
Author(s):  
G. Merault ◽  
L. Keclard ◽  
C. Saint-Martin ◽  
K. Jasmin ◽  
A. Campier ◽  
...  

1981 ◽  
Vol 11 (2) ◽  
pp. 137-145 ◽  
Author(s):  
W. F. Moo-Penn ◽  
P. McPhedran ◽  
S. Bobrow ◽  
M. H. Johnson ◽  
D. L. Jue ◽  
...  

Hemoglobin ◽  
1991 ◽  
Vol 15 (1-2) ◽  
pp. 53-65 ◽  
Author(s):  
P. F. Como ◽  
B. R. Wylie ◽  
R. J. Trent ◽  
D. Bruce ◽  
F. Volpato ◽  
...  

Hemoglobin ◽  
1987 ◽  
Vol 11 (3) ◽  
pp. 221-230 ◽  
Author(s):  
D. Williamson ◽  
R. M.G. Wells ◽  
R. Anderson ◽  
J. Matthews

FEBS Letters ◽  
1978 ◽  
Vol 92 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Winston F. Moo-Penn ◽  
James A. Wolff ◽  
Gilbert Simon ◽  
Marie Vaček ◽  
Danny L. Jue ◽  
...  

2020 ◽  
Vol 509 ◽  
pp. 177-179
Author(s):  
Joanna Jung ◽  
Emily Garnett ◽  
Beverley Vispo ◽  
Xinpu Chen ◽  
Jing Cao ◽  
...  

Hemoglobin ◽  
2002 ◽  
Vol 26 (2) ◽  
pp. 169-174 ◽  
Author(s):  
Claude Préhu ◽  
Lütje J. Behnken ◽  
Rüdiger Neumann ◽  
Jean Riou ◽  
Jean Kister ◽  
...  

2003 ◽  
Vol 121 (1) ◽  
pp. 28-30
Author(s):  
Sylvia Morais de Sousa ◽  
Letícia Khater ◽  
Luís Antônio Peroni ◽  
Karine Miranda ◽  
Marcelo Jun Murai ◽  
...  

CONTEXT: We verified molecular alterations in a 72-year-old Brazilian male patient with a clinical course of homozygous beta-thalassemia intermedia, who had undergone splenectomy and was surviving without regular blood transfusions. The blood cell count revealed microcytic and hypochromic anemia (hemoglobin = 6.5 g/dl, mean cell volume = 74 fl, mean cell hemoglobin = 24 pg) and hemoglobin electrophoresis showed fetal hemoglobin = 1.3%, hemoglobin A2 = 6.78% and hemoglobin A = 79.4%. OBJECTIVE: To identify mutations in a patient with the symptoms of beta-thalassemia intermedia. DESIGN: Molecular inquiry into the mutations possibly responsible for the clinical picture described. SETTING: The structural molecular biology and genetic engineering center of the Universidade Estadual de Campinas, Campinas, Brazil. PROCEDURES: DNA extraction was performed on the patient's blood samples. The polymerase chain reaction (PCR) was done using five specific primers that amplified exons and the promoter region of the beta globin gene. The samples were sequenced and then analyzed via computer programs. RESULTS: Two mutations that cause the disease were found: -101 (C > T) and codon 39 (C > T). CONCLUSIONS: This case represents the first description of 101 (C > T) mutation in a Brazilian population and it is associated with a benign clinical course.


Sign in / Sign up

Export Citation Format

Share Document